Tumor necrosis factor alpha-induced vascular leakage involves PECAM1 phosphorylation

Cancer Res. 1996 Jul 15;56(14):3211-5.

Abstract

Herein we show that exposure of human umbilical vein endothelial cells to tumor necrosis factor alpha (TNFalpha) led to platelet endothelial cell adhesion molecule-1 (PECAM1) surface redistribution, disruption of cytoskeleton connections, and increased PECAM1 phosphorylation, accompanied by increased permeability to macromolecules. The in vitro use of inhibitors of tyrosine or serine-threonine kinases could prevent both PECAM1 surface redistribution and the increase in permeability induced by the cytokine. In vivo administration of lavendustin A, a natural tyrosine kinase inhibitor, protected endothelial cells from TNFalpha-dependent vascular leakage in mouse liver. We propose that the involvement of PECAM1 in TNFalpha-mediated effects on vascular permeability may depend on a dynamically regulated cytoskeletal association, related to the degree of PECAM1 phosphorylation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alkaloids / pharmacology
  • Antigens, Differentiation, Myelomonocytic / metabolism*
  • Benzoquinones
  • Capillary Permeability / drug effects*
  • Cell Adhesion Molecules / metabolism*
  • Cell Compartmentation
  • Cells, Cultured
  • Endothelium, Vascular / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Fluorescent Antibody Technique, Indirect
  • Gene Expression
  • Humans
  • Lactams, Macrocyclic
  • Phosphorylation
  • Platelet Endothelial Cell Adhesion Molecule-1
  • Protein Kinase Inhibitors
  • Quinones / pharmacology
  • RNA, Messenger / genetics
  • Rifabutin / analogs & derivatives
  • Staurosporine
  • Tumor Necrosis Factor-alpha / pharmacology*
  • Umbilical Veins

Substances

  • Alkaloids
  • Antigens, Differentiation, Myelomonocytic
  • Benzoquinones
  • Cell Adhesion Molecules
  • Enzyme Inhibitors
  • Lactams, Macrocyclic
  • Platelet Endothelial Cell Adhesion Molecule-1
  • Protein Kinase Inhibitors
  • Quinones
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Rifabutin
  • herbimycin
  • Staurosporine